Our results expand upon previous studies by showing that the numbers of all subpopulations of CD4+ helper T cells (naïve, central memory, effector memory, and effector) were significantly lower in stage IV IBC patients, whereas reductions within CD8+ cytotoxic T lymphocytes were more concentrated in the memory subsets. This evidence concerns the gene CD4 and inflammatory breast carcinoma.